NagS is a novel GlcNAc-6P dehydratase.

NagS is a novel GlcNAc-6P dehydratase.

<p><b>(a)</b> Sensitivity of <i>S. coelicolor</i> mutants to GlcNAc. Spores (5 × 10<sup>5</sup> CFU) of <i>S. coelicolor</i> M145 and its mutant derivatives ∆<i>nagB</i>, SMA11, ∆<i>nagB</i>∆<i>nagS</i>, ∆<i...

保存先:

書誌詳細
第一著者:	Chao Li (145513) (author)
その他の著者:	Mia Urem (22683580) (author), Ioli Kotsogianni (9930187) (author), Josephine Lau (20442343) (author), Chao Du (288036) (author), Somayah S. Elsayed (9192571) (author), Nathaniel I. Martin (847378) (author), Iain W. McNae (840777) (author), Patrick Voskamp (2311429) (author), Christoph Mayer (57204) (author), Sébastien Rigali (724082) (author), Navraj Pannu (10163763) (author), Jan Pieter Abrahams (1429531) (author), Lennart Schada von Borzyskowski (22683583) (author), Gilles P. van Wezel (7838948) (author)
出版事項:	2025
主題:	Biochemistry Microbiology Ecology Developmental Biology Inorganic Chemistry Biological Sciences not elsewhere classified controls nutrient signaling also revealed 6 highlighted key residues glcnac sensing requires toxicity pathway dependent 6p deacetylase naga novel glcnac 6 key role substrate glcnac novel enzyme work uncovers wall leads unprecedented reaction substrate mycelium structural analogue streptomycetaceae </ streptomyces </ revolves around promiscuous activity nature ’ n </ multicellular lifestyle metabolic checkpoint medicine makers lytic dismantling landmark event hyphal cell highly conserved growth media function analysis clinical antibiotics central metabolism catalytic inhibitor antibiotic production active site >- acetylglucosamine 6p dehydratase
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Roles of NagS and NagA in GlcNAc toxicity.
著者:: Chao Li (145513)
出版事項: (2025)

Model for the metabolic control of development by GlcNAc and NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Inhibition of siderophore production by GlcNAc requires NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Kinetics of <i>S. coelicolor</i> NagA and the product identification of NagS-NagA catalysis.
著者:: Chao Li (145513)
出版事項: (2025)

Analysis of the binding site of NagS and activity of NagS mutants.
著者:: Chao Li (145513)
出版事項: (2025)

Kinetic parameters for <i>S. coelicolor</i> NagS and NagA.
著者:: Chao Li (145513)
出版事項: (2025)

Crystal structure of NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Phylogenomic analysis of NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Kinetics of NagS variants.
著者:: Chao Li (145513)
出版事項: (2025)

Catalytic substrates of NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Extinction coefficient measurement of NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Function determination and kinetics of NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Substrate binding pocket and the movable loop of NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Activity test of NagS homologs in vitro and in vivo.
著者:: Chao Li (145513)
出版事項: (2025)

Size-exclusion chromatography analysis of purified NagS.
著者:: Chao Li (145513)
出版事項: (2025)

Inhibitory effect of 6-phosphogluconate (6-PG) on NagS.
著者:: Chao Li (145513)
出版事項: (2025)

NagS is a conserved protein amongst Streptomycete organisms.
著者:: Chao Li (145513)
出版事項: (2025)

New function of <i>S. coelicolor</i> NagA and an updated amino sugar metabolic pathway.
著者:: Chao Li (145513)
出版事項: (2025)

Data underlying figures.
著者:: Chao Li (145513)
出版事項: (2025)

Spectroscopic data of compound 1.
著者:: Chao Li (145513)
出版事項: (2025)

Metabolic pathway of aminosugar in <i>Streptomyces.</i>
著者:: Chao Li (145513)
出版事項: (2025)

Image 1_Vitamin D supplementation and its impact on leptin and interleukin-6 in women following religious intermittent fasting: a controlled study.png
著者:: Spyridon N. Karras (22080581)
出版事項: (2025)

Table 1_Comparative analysis of the therapeutic effect of antibiotic bone cement on Wagner grade 3 or 4 diabetic foot ulcer in heel and non-heel areas: a retrospective cohort study.docx
著者:: Yang Jian (5274260)
出版事項: (2025)

Medication-inclusive multivariable logistic regression for MAFLD.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Multivariable logistic regression models for MAFLD predictors.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Liver Stiffness and Fibrosis Grading by MAFLD Status.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Comparison of Non-invasive Liver Fibrosis Scores.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Demographic and Clinical Characteristics of Study Participants.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Proposed pathophysiological crosstalk between MAFLD and CKD.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Stratification of Liver Stiffness according to eGFR in the MAFLD group.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black).
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

eGFR in the study participants.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years).
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years).
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years).
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

<b>Multi-dimensional Resource Synergy and Coded Computation Theory for 6G Satellite-Terrestrial Integrated Networks</b>
著者:: f y (22066025)
出版事項: (2025)

CMIP6 historical and future SSP scenarios dataset
著者:: Xuanze Zhang (8343456)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_20du09a16ji9m0s95nopv146e7